Spring MIT
June 17 - 18
Koch Institute at MIT
In order to further cultivate biomedical innovation and the advancement of medicines to help patients, Longwood Healthcare Leaders is gathering thought leaders across pharma, biotech, government, academia, healthcare, and investing for two days of discussion and networking. Join us June 17-18 for this not-to-be missed event at MIT’s Koch Institute.
Longwood Healthcare Leaders Spring MIT is co-hosted by
MIT Institute Professors Bob Langer and Phil Sharp
.jpg)
2024 Featured Speakers
Regulatory & Public Policy Leaders
Academia & Research
BioPharma CEOs
Pharma R&D Leaders
BD & Strategy Leaders
Venue
Longwood Healthcare Leaders Spring MIT
will be held at MIT’s Koch Institute
500 Main Street, Cambridge, MA
in Cambridge’s Kendall Square.
2024 Agenda
7:00 am
REGISTRATION & NETWORKING BREAKFAST
7:30 am
LONGWOOD FUND INTRODUCTION
Aleks Radovic-Moreno, Partner, Longwood Fund
8:00 am
(BIG BIO)PHARMA PIPELINE SOURCING
Johanna Bendell, Global Head Oncology, Pharma Research & Early Development, Roche
Fawzi Benzaghou, SVP, Global Head, Oncology, Ipsen
Francisco Ramirez-Valle, SVP, Head, Immunology & Cardiovascular Research, Bristol Myers Squibb
Badhri Srinivasan, Head, Global Clinical Operations, Novartis
Moderator: Alberto Santagostino, SVP, Head, Cell & Gene Technologies, Lonza
8:30 am
TRANSLATING SCIENCE INTO MEDICINE
Sek Kathiresan, CEO, Verve Therapeutics
John Lepore, CEO, ProFound Therapeutics
Søren Møller, Managing Partner, Novo Holdings
Joanna Stanicka, CEO, Axonis Therapeutics
Brent Vaughan, CEO, Cognito Therapeutics
Moderator: Teresa Bitetti, President, Global Oncology, Takeda
9:00 am
DRIVING PRODUCTIVITY IN R&D
Ivan Cheung, CEO, NextPoint Therapeutics
Jak Knowles, CEO, Affini-T
Martin Mackay, Chair, RallyBio
Joanne Smith-Farrell, CEO, Be Bio
Moderator: Yiannis Kiachopoulos, CEO, Causaly
9:30 am
REGULATORY, GOVERNANCE & INDUSTRY ROUNDTABLE
Victor Dzau, President, National Academy of Medicine
Peter Marks, Director, CBER, FDA
Moderator: Christoph Westphal, General Partner, Longwood Fund
9:50 am
NETWORKING BREAK
10:15 am
TARGETED LICENSING & ACQUISITIONS
David Meek, former CEO, Mirati Therapeutics
Gilmore O’Neill, CEO, Editas Medicine
Deniz Razon, CBO, Servier Pharmaceuticals
Devyn Smith, CEO, Arbor Bio
Moderator: Caleb Bates, Principal, Fish & Richardson
10:45 am
INNOVATION IN DRUG DISCOVERY
Brant Binder, President, Bonito Biosciences
Frank Laukien, CEO, Bruker
Gustavo Mahler, CEO, Ncardia
Jen Michaelson, CSO, Cullinan Oncology
Raj Prasad, CFO, Crispr Therapeutics
Moderator: Jeb Keiper, CEO, Nimbus Therapeutics
11:20 am
FIRESIDE CHAT
Chris Viehbacher, CEO, Biogen
Phil Sharp, Institute Professor, MIT; Scientific Co-Founder, Biogen
Moderator: Christoph Westphal, General Partner, Longwood Fund
11:40 am
FIRESIDE CHAT: GLOBAL INVESTMENTS
Fidah Alsagoff, Vice Chair, Life Sciences, Temasek
Rick Slocum, Chief Investment Officer, Harvard Management Company
Rod Wong, Managing Partner, RTW Funds
Moderator: Christoph Westphal, General Partner, Longwood Fund
12:00 pm
NETWORKING LUNCHEON
1:00 pm
THE FUTURE OF MENTAL HEALTHCARE
Guy Goodwin, CMO, COMPASS Pathways
Anne Klibanski, President & CEO, Mass General Brigham
Vikram Sudarsan, CEO, Engrail Therapeutics
Moderator: Deborah Dunsire, former CEO, Lundbeck
1:30 pm
FIRESIDE CHAT
Sally Kornbluth, President, MIT
Ed Markey, Senator, Massachusetts
Moderator: Christoph Westphal, General Partner, Longwood Fund
2:00 pm
NAVIGATING PARTNERSHIPS ACROSS BORDERS
Monika Paule, CEO, Caszyme
Rajinder Khunkhun, Head, Neuroscience BD, Takeda
Stefen Laukien, Co-Founder & President, Retroviral Therapeutics
Ningshu Liu, CSO, Fosun Pharma
Moderator: Neil Abdollahian, CBO, Boundless Bio
2:30 pm
NETWORKING BREAK
3:00 pm
GETTING TO REGULATORY APPROVAL
Aine Hanly, CTO, Vir Bio
Peter Hutt, former General Counsel, FDA
Vikram Karnani, EVP, Global Commercial & Medical Affairs, Rare Disease, Amgen
Moderator: Uma Sharma, CEO, MMS Holdings
3:30 pm
INNOVATIVE COMMERCIAL MODELS
Sharon Benzeno, CCO, Immune Medicine, Adaptive Biotechnologies
Tom Klima, CCO & COO, bluebird bio
Rachid Izzar, EVP, Head, Global Product Strategy & Commercialization, Biogen
Scott Weintraub, SVP, US Business, Alexion, AstraZeneca Rare Disease
Moderator: Dave Provost, SVP, Development, BXP
4:00 pm
MAINTAINING PATIENT-CENTRIC FOCUS
Meg Alexander, Chief Strategy Officer, Ovid Therapeutics
William Dahut, CSO, American Cancer Society
Kristophe Diaz, Executive Director & CSO, CurePSP
Edward Kaye, CEO, Stoke Therapeutics
Moderator: Jane Wilkinson, CEO, CANCollaborate
4:30 pm
DEVELOPING A STRONG SYNDICATE
Ray Camahort, Partner, Venture Investments, Novo Ventures
Ansbert Gadicke, Managing Partner, MPM BioImpact
Steve Tregay, Managing General Partner, Mission BioCaptial
Moderator: Aleks Radovic-Moreno, Partner, Longwood Fund
5:00 – 7:00 pm
COCKTAIL RECEPTION
Day 1
Day 2
7:00 am
REGISTRATION & NETWORKING BREAKFAST
7:30 am
LONGWOOD FUND INTRODUCTION
David Steinberg, General Partner, Longwood Fund
8:00 am
MODERATED KEYNOTE
Jake Auchincloss, U.S. Representative, Massachusetts
Co-Moderator: Edward Kaye, CEO, Stoke Therapeutics
Christoph Westphal, General Partner, Longwood Fund
8:20 am
IDENTIFYING NEXT-GENERATION THERAPEUTICS
Omar Abudayyeh, Assistant Professor, Harvard Medical School
Carl Hansen, CEO, Abcellera
Arnaud Lacoste, CSO, Aurion Biotech
Al Sandrock, CEO, Voyager Therapeutics
Joel Schneider, CEO, Carbon Biosciences
Moderator: Lisa Ricciardi, CEO, Cognition Therapeutics
8:55 am
INNOVATION IN CLINICAL TRIALS
Brian Alexander, SVP, Pharma R&D, Roche Genentech
Leslie Meltzer, CMO, Orchard Therapeutics
Sarah Sheikh, Head, Global Development & SVP, Neuroscience, Takeda
Joe Stauffer, CMO, Antibe Therapeutics
Moderator: Kailash Swarna, Managing Director, Global Head, Clinical Development, Accenture
9:25 am
FIRESIDE CHAT
Todd Golub, Director, Founding Core Institute Member, The Broad Institute of MIT and Harvard
Rochelle Walensky, Director, CDC (2021-2023)
Moderator: George Daley, Dean, Harvard Medical School
9:45 am
NETWORKING BREAK
10:15 am
ACCELERATING DRUG DEVELOPMENT
Paul Kingma, Chief Medical Advisor, Myra EB Systems
Chris Loose, CEO, Progentos
Oliver Rosen, CMO, Akamis Bio
Priya Singhal, EVP, Head, Development, Biogen
Moderator: Brian Taylor, CEO, SmartLabs
10:45 am
MANAGING THE RUNWAY
Dror Harats, CEO, ImmuneWalk Therapeutics
Anna Kazanchyan, CEO, Saghmos Therapeutics
Pratik Shah, CEO, Design Therapeutics
Brendan Smith, CEO, Doppler Bio
Moderator: Paul Peter Tak, CEO, Candel Therapeutics
11:15 am
PLATFORM TO PIPELINE
Rachel Humphrey, CEO, Normunity
Geoff McDonough, CEO, Generation Bio
Mittul Mehta, CIO & Head, AI, Tevogen
Leslie Williams, CEO, HC Bioscience
Moderator: Zhen Su, CEO, Marengo Therapeutics
11:45 pm
FIRESIDE CHAT: LEVERAGING TECHNOLOGY TO ADVANCE PHARMA R&D
Andy Plump, President, R&D, Takeda
Dave Reese, Chief Technology Officer, Amgen
Moderator: David Steinberg, General Partner, Longwood Fund
12:05 pm
NETWORKING LUNCHEON & GUBERNATORIAL KEYNOTE
Massachusetts Governor Maura Healey will share a moderated keynote during the luncheon, followed by audience Q&A.
1:00 pm
ADVANCING LATE STAGE ASSETS
Brian Goff, CEO, Agios
Caroline Loew, CEO, Mural Oncology
Kinnari Patel, President & COO, Rocket Pharma
Moderator: Al Beardsley, COO, Galera Therapeutics
1:30 pm
ENSURING HEALTH EQUITY & ACCESS
Abe Ceesay, CEO, Rapport Therapeutics
Laurie Glimcher, CEO, Dana-Farber Cancer Institute
Rob Perez, Chair, Life Science Cares
Pierre Theodore, Executive Director, Patient Impact and Health Equity, Genentech
Moderator: Ariel Katz, CEO, H1
2:00 pm
FIRESIDE CHAT
Stephen Hoge, President, Moderna
Bob Langer, Institute Professor, MIT; Scientific Co-Founder, Moderna
Moderator: Kailash Swarna, Managing Director, Accenture
2:20 pm
R&D COLLABORATION
Melissa Bonner, CSO, Nvelop
Frank DeRosa, Chief Technology Officer, Global Head, Research, mRNA Center of Excellence, Sanofi
David Donabedian, Executive Partner, Interim NewCo CEO, Longwood Fund
Samir Hanash, Department Head, Early Detection and Treatment of Cancer, MD Anderson
Moderator: Cheryl Reicin, Partner, Mintz
2:50 pm
NETWORKING BREAK
3:20 pm
FIRESIDE CHAT
Mikael Dolsten, CSO & President, R&D, Pfizer
Christophe Weber, CEO, Takeda
Moderator: Christoph Westphal, General Partner, Longwood Fund
3:40 pm
INVESTMENT OUTLOOK
Deepak Abraham, CEO, FGEN Ltd
Delian Asparouhov, Partner, Founders Fund
Lucy Liu, Principal, Longwood Fund
Dan Omstead, CEO, Tekla Capital
Moderator: Jim Reddoch, EVP, Investments & CSO, Royalty Pharma
4:10 pm
ECOSYSTEM OF EXTERNAL INNOVATION
Amit Agrawal, CSO, Diagnostics, Danaher Corporation
Jessica Ballinger, CEO, Lyndra
Woody Sherman, CIO, Psivant Therapeutics
Uli Stilz, VP, Bio Innovation Hub, Novo Nordisk
Moderator: Bob Silverman, CBO, Turbine Simulated Cell Technologies
